By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Synthetic Biologics, Inc. (SYN)' Academic Collaborator To Present Novel Monoclonal Antibody Combination For Treating Whooping Cough (Pertussis) At Gordon Research Conference 7/21/2014 12:00:48 PM
Synthetic Biologics, Inc. (SYN) Forms Clinical Advisory Board to Support Novel C. difficile Preventative Program 6/30/2014 9:53:20 AM
Synthetic Biologics, Inc. (SYN) Reports That Licensor Cedars-Sinai Medical Center Finds Eradication Of Gut Methane Improves Insulin Sensitivity And Lipid Profiles In Study Of Pre-Diabetic, Obese Patients 6/25/2014 6:36:24 AM
Synthetic Biologics, Inc. (SYN) To Present At The 3rd Annual Marcum LLP Microcap Conference 5/21/2014 6:15:54 AM
Synthetic Biologics, Inc. (SYN) Reports First Quarter 2014 Financial Results And Operational Highlights 5/15/2014 7:27:06 AM
Synthetic Biologics, Inc. (SYN) Announces Recent International Patents That Bolster Its C. Difficile Program 5/8/2014 9:05:38 AM
Synthetic Biologics, Inc. (SYN) To Discuss Phase II Results Of Oral Estriol Candidate Trimesta™ For Relapsing-Remitting Multiple Sclerosis In Women 4/30/2014 9:51:19 AM
Synthetic Biologics, Inc. (SYN) Reports University of California, Los Angeles (UCLA) Announcement Of Preliminary Positive Topline Efficacy And Safety Results From Investigator-Led Phase 2 Study Of Trimesta™ For Relapsing-Remitting Multiple Sclerosis 4/29/2014 3:53:28 PM
Synthetic Biologics, Inc. (SYN)' Reports Preclinical Data To Support Clinical Development Of Novel Pertussis Therapeutic 4/23/2014 9:01:34 AM
Synthetic Biologics, Inc. (SYN) Appoints Mark Pimentel, M.D., Chairman Of New Irritable Bowel Syndrome Clinical Advisory Board 4/14/2014 6:15:29 AM
12345678910...
//-->